Navigation Links
Obesity-Related Inflammation Boosts Heart Risks
Date:5/6/2008

Blood chemicals in overweight participants were key predictors of organ failure, study says

TUESDAY, May 6 (HealthDay News) -- Obesity causes prolonged inflammation of heart tissue that in turn boosts heart failure risk, according to a U.S. study of almost 7,000 people.

The latest findings from the Multiethnic Study of Atherosclerosis (MESA) are believed to provide the first large scale of evidence of such a link and give the estimated 72 million obese American adults another reason to change their lifestyle.

"The biological effects of obesity on the heart are profound. Even if obese people feel otherwise healthy, there are measurable and early chemical signs of damage to their heart, beyond the well-known implications for diabetes and high blood pressure," senior study investigator Dr. Joao Lima, a professor of medicine and radiology at the Johns Hopkins University School of Medicine and its Heart Institute, said in a prepared statement.

There is "now even more reason for (obese people) to lose weight, increase their physical activity and improve their eating habits," Lima said.

He and his colleagues tracked the development of heart failure in an ethnically diverse group of nearly 7,000 people, ages 45 to 84, who enrolled in the MESA study, starting in 2000. Of the 79 participants who've developed congestive heart failure so far, 35 (44 percent) were physically obese (body mass index of 30 or greater).

On average, obese participants were found to have higher blood levels of key immune system proteins involved in inflammation (interleukin 6, C-reactive protein, and fibrinogen) than non-obese participants. A near doubling of average interleukin 6 levels alone was associated with an 84 percent increased risk of heart failure.

"Our results showed that when the effects of other known disease risk factors -- including race, age, sex, diabetes, high blood pressure, smoking, family history and blood cholesterol levels -- were statistically removed from the analysis, inflammatory chemicals in the blood of obese participants stood out as key predictors of who got heart failure," Lima said.

He added that doctors "need to monitor their obese patients for early signs of inflammation in the heart and to use this information in determining how aggressively to treat the condition."

Lima and colleagues also found a link between inflammation and metabolic syndrome, which doubles a person's chances of developing heart failure. Metabolic syndrome is a collection of risk factors -- obesity, high blood pressure, elevated blood glucose levels, excess abdominal fat, and abnormal cholesterol levels -- that increase the risk of heart disease and diabetes.

The study was published in the May 6 issue of the Journal of the American College of Cardiology. The MESA study was expected to continue tracking patients through 2012.

More information

The American Heart Association has more about heart failure.



-- Robert Preidt



SOURCE: Johns Hopkins Medicine, news release, May 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cyberonics Licenses Obesity-Related Patents
2. Pathway links inflammation, angiogenesis and breast cancer
3. New insights into inflammation in osteoarthritis
4. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
5. Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
6. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
7. Inflammation Cant Explain Depressions Link to Heart Disease
8. UC Davis researchers discover novel pathway to increased inflammation in diabetes patients
9. Exercise may play role in reducing inflammation in damaged skin tissue
10. Researchers develop powerful tool to study the genetics of inflammation
11. Low-carb diet reduces inflammation and blood saturated fat in metabolic syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... ... appointment of Mike Finnegan to the position of Executive Vice President, Sales and ... in healthcare technology, telehealth and medical device sales leadership. He has received industry ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... many of the health care industry’s hospitals and provider groups, has announced that ... for select customers. Parasail Health is a San Francisco health-finance startup that has ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article ... reach a staggering $6.81 billion by the year 2024 according to a new report. ... rate than those made from titanium. Los Angeles area clinic Beverly Hills Periodontics & ...
(Date:6/27/2017)... ... June 27, 2017 , ... Atmosera , ... Atmosera Managed Azure Services . The trusted, transparent, and secure solution for the ... growing customer base. Atmosera’s next generation services include integrated capabilities for public, private, ...
(Date:6/27/2017)... ... June 27, 2017 , ... Today, June 27th is ... PTSD. Yet less than 20% will receive adequate care due to lack of effective ... receive any care at all. And left untreated, veterans are at an increased risk ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology: